SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-057436
Filing Date
2020-05-06
Accepted
2020-05-06 16:16:18
Documents
61
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014426-1_10q.htm 10-Q 432421
2 EXHIBIT 31.1 tm2014426d1_ex31-1.htm EX-31.1 10344
3 EXHIBIT 31.2 tm2014426d1_ex31-2.htm EX-31.2 10121
4 EXHIBIT 32.1 tm2014426d1_ex32-1.htm EX-32.1 5355
  Complete submission text file 0001104659-20-057436.txt   4166545

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cldx-20200331_def.xml EX-101.DEF 107119
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cldx-20200331_lab.xml EX-101.LAB 313528
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cldx-20200331_pre.xml EX-101.PRE 230310
8 XBRL INSTANCE DOCUMENT cldx-20200331.xml EX-101.INS 1165434
9 XBRL TAXONOMY EXTENSION SCHEMA cldx-20200331.xsd EX-101.SCH 28229
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cldx-20200331_cal.xml EX-101.CAL 41301
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 20852811
SIC: 2835 In Vitro & In Vivo Diagnostic Substances